| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-11 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-07 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-06 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.13 | 1e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |